Protocol for a Multi-Center Confirmatory Trial to Evaluate the Differential Diagnostic Performance of Contrast-Enhanced Ultrasonography Using Perflubutane in Patients with a Pancreatic Mass: A Multicenter Prospective Study

Bibliographic Details
Title: Protocol for a Multi-Center Confirmatory Trial to Evaluate the Differential Diagnostic Performance of Contrast-Enhanced Ultrasonography Using Perflubutane in Patients with a Pancreatic Mass: A Multicenter Prospective Study
Authors: Yasunobu Yamashita, Toshio Shimokawa, Reiko Ashida, Yoshiki Hirooka, Takuji Iwashita, Hironari Kato, Toshifumi Kin, Atsushi Masamune, Haruo Miwa, Eizaburo Ohno, Hideyuki Shiomi, Atsushi Sofuni, Mamoru Takenaka, Masayuki Kitano
Source: Diagnostics, Vol 14, Iss 2, p 130 (2024)
Publisher Information: MDPI AG, 2024.
Publication Year: 2024
Collection: LCC:Medicine (General)
Subject Terms: contrast-enhanced transabdominal ultrasonography, contrast-enhanced endoscopic ultrasonography, pancreatic cancer, perflubutane, Medicine (General), R5-920
More Details: For pancreatic masses, an evaluation of their vascularity using contrast-enhanced ultrasonography can help improve their characterization. This study was designed to evaluate the utility and safety of contrast-enhanced transabdominal ultrasonography (CE-TUS) and endoscopic ultrasonography (CE-EUS) in the diagnosis of pancreatic masses including solid or cystic masses. This multi-center comparative open-label superiority study is designed to compare Plain (P)-TUS/EUS alone with P-TUS/P-EUS plus CE-TUS/CE-EUS. Three hundred and one patients with a total of 232 solid pancreatic masses and 69 cystic masses were prospectively enrolled. The primary endpoints are to compare the diagnostic accuracy between P-TUS/P-EUS alone and P-TUS/P-EUS plus CE-TUS/CE-EUS for both the TUS and EUS of solid pancreatic masses, and to compare the diagnostic accuracy between P-EUS alone and P-EUS plus CE-EUS in cystic pancreatic masses. The secondary endpoints are to compare the diagnostic sensitivity and specificity of P-TUS/P-EUS alone and P-TUS/P-EUS plus CE-TUS/CE-EUS for pancreatic solid/cystic masses, and the accuracy of P-TUS alone and P-TUS plus CE-TUS for pancreatic cystic masses. Other secondary endpoints included comparing the diagnostic sensitivity, specificity, and accuracy of CE-TUS, CE-EUS and CE-computed tomography (CT) for solid/cystic pancreatic masses. The safety, degree of effective enhancement, and diagnostic confidence obtained with CE-TUS/CE-EUS will also be assessed.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 14020130
2075-4418
Relation: https://www.mdpi.com/2075-4418/14/2/130; https://doaj.org/toc/2075-4418
DOI: 10.3390/diagnostics14020130
Access URL: https://doaj.org/article/8057534cdb684c699963636dfe8a9709
Accession Number: edsdoj.8057534cdb684c699963636dfe8a9709
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:14020130
20754418
DOI:10.3390/diagnostics14020130
Published in:Diagnostics
Language:English